Citigroup
KRTX

Citigroup’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Citigroup’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-141,738
Closed -$44.9M – 5913
2023
Q4 		$44.9M Buy
141,738
+104,913
+285% +$20.4M 0.03% 503
2023
Q3 		$6.23M Buy
36,825
+17,537
+91% +$3.3M ﹤0.01% 1326
2023
Q2 		$4.18M Sell
19,288
-14,120
-42% -$3.03M ﹤0.01% 1615
2023
Q1 		$6.07M Buy
33,408
+13,750
+70% +$2.63M ﹤0.01% 1395
2022
Q4 		$3.86M Sell
19,658
-7,505
-28% -$1.61M ﹤0.01% 1609
2022
Q3 		$6.11M Sell
27,163
-12,986
-32% -$2.63M ﹤0.01% 1438
2022
Q2 		$5.08M Buy
40,149
+29,839
+289% +$3.43M ﹤0.01% 1533
2022
Q1 		$1.31M Sell
10,310
-61,573
-86% -$6.93M ﹤0.01% 2714
2021
Q4 		$9.42M Buy
71,883
+49,615
+223% +$6.41M 0.01% 1417
2021
Q3 		$2.72M Sell
22,268
-12,212
-35% -$1.41M ﹤0.01% 2294
2021
Q2 		$3.93M Sell
34,480
-3,557
-9% -$416K ﹤0.01% 2123
2021
Q1 		$4.57M Buy
38,037
+28,270
+289% +$3.2M ﹤0.01% 1847
2020
Q4 		$992K Buy
9,767
+1,328
+16% +$123K ﹤0.01% 3549
2020
Q3 		$653K Sell
8,439
-12,815
-60% -$1.09M ﹤0.01% 3623
2020
Q2 		$2.37M Buy
21,254
+10,657
+101% +$927K ﹤0.01% 2627
2020
Q1 		$763K Buy
10,597
+6,212
+142% +$531K ﹤0.01% 3449
2019
Q4 		$331K Buy
4,385
+4,182
+2,060% +$183K ﹤0.01% 4772
2019
Q3 		$3K Sell
203
-11,297
-98% -$220K ﹤0.01% 7495
2019
Q2 		$230K Buy
+11,500
New +$230K ﹤0.01% 5138

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Citigroup's KRTX Position: Q1 2024 in Review

Citigroup sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 141,738 shares — an estimated $44.9M sold.

Citigroup first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $44.9M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Citigroup reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 141,738 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $44.9M.
  • Citigroup first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • Citigroup's Karuna Therapeutics, Inc. Common Stock position peaked at $44.9M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.